Published in Hematology Week, August 6th, 2007
The August issue of the journal Anesthesiology features a study showing that a newly developed "hemoglobin-based oxygen carrier" (HBOC) called HRC 101 (Hemosol, Mississauga, Ontario, Canada) dramatically improves survival in mice with "sickled" red blood cells exposed to low-oxygen conditions. "HRC 101 warrants further evaluation as a therapeutic modality in sickle cell disease," concludes the study, led by Dr. Mark W. Crawford of The Hospital for Sick Children, University of Toronto.
Dr. Crawford...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2007-08-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.